HOME › DRUGS › BRENTUXIMAB VEDOTIN
ACTIVE SUBSTANCE / INN

BRENTUXIMAB VEDOTIN

Brand name(s): ADCETRIS, Adcetris
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA125388
Lymphoma, Non-Hodgkin;Hodgkin Disease
ACTIVE SUBSTANCE
Brentuximab Vedotin
REGULATORS
FDA · EMA
SPONSORS / MAH
SEATTLE GENETICS, Takeda Pharma A/S
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ADCETRISBLA125388SEATTLE GENETICSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AdcetrisTakeda Pharma A/SAuthorised25/10/2012Lymphoma, Non-Hodgkin;Hodgkin Disease

FULL INTELLIGENCE ON BRENTUXIMAB VEDOTIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →